US-based generics maker Perrigo Company (Perrigo) announced on 29 July 2013 that it would acquire Irish biotechnology company Elan Corporation (Elan) for US$8.6 billion.
Perrigo expands global ambitions with Elan buy
Home/Pharma News
|
Posted 16/08/2013
1
Post your comment
The cash and shares deal fits well with Perrigo’s global expansion ambitions, as well as significantly reducing the company’s tax bill, as it takes advantage of Ireland’s corporate tax rate. Perrigo expects savings in tax and operating costs of more than US$150 million by moving its headquarters to Ireland, where corporation tax is 12.5% compared with the US rate of 35%.
The deal will also give Perrigo access to royalty income from Elan’s blockbuster multiple sclerosis treatment Tysabri (natalizumab). Tysabri generated revenues of US$1.6 billion last year and has been growing at a compound annual growth rate of 19%.
‘Through this transaction, Perrigo establishes a diversified platform for further international expansion’, stated Perrigo Chairman and CEO, Mr Joseph C Papa. He added that ‘the combination of Perrigo and Elan will create an industry-leading global healthcare company’ which can ‘capitalize on international market opportunities’.
Under the terms of the agreement Perrigo, which will give Perrigo shareholders 71% of the company, will pay Elan shareholders US$6.25 in cash and 0.07636 in shares of the new Perrigo for each Elan share. This assumes a value of each Elan share at US$16.50 based on the closing price per Perrigo share on 26 July 2013. This somewhat vindicates Elan’s management, who rejected a bid from Royalty Pharma in June 2013 for US$13 a share in cash and a further contingent value right, worth up to US$2.50 a share.
Perrigo started as a packager and distributer of patented medicines and household items back in 1887, and has since expanded into a global generics manufacturer with headquarters in the US and a presence in Australia, China, India, Israel, Mexico and the UK.
Related articles
Perrigo buys Paddock for US$540 million
Rights to Allegra acquired by generics’ manufacturer Perrigo
Permission granted to reproduce for personal and non-commercial use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.
Copyright – Unless otherwise stated all contents of this website are © 2013 Pro Pharma Communications International. All Rights Reserved.
Source: Perrigo
Posted 21/08/2026 by Rhonda Schreuder
I was diagnosed in 1996, before symptoms started. I am a pianist, suddenly unable to open my hands wide enough to get 8 keys. Nobody in my family had MS, nor my grandparents. Last year a cousin younger than me had MS, she is 40. I have primary progressive MS. I do not walk for the last 18 years, I was born in 1962. I have had 6 strokes and 1 heart attack. The Rebif (beta-1a) did very little to help me. The medical team did even less. After roughly five unending years of trauma in the family my MS developed into progressive. There have been many changes in the last 3 to 4 years. Many falls, many fractured bones, and three moves all in five years. I have gone downhill. Considerably. I used different supplements that didn't work. I started on MS-4 Protocol from www. Limitlessnaturalwellness .com , the MS-4 Protocol immensely helped my Multiple Sclerosis condition, I'm able to walk and the constant fatigues are gone. My life is back. I Adhere anyone reading this to try natural approach.
I was diagnosed in 1996, before symptoms started. I am a pianist, suddenly unable to open my hands wide enough to get 8 keys. Nobody in my family had MS, nor my grandparents. Last year a cousin younger than me had MS, she is 40. I have primary progressive MS. I do not walk for the last 18 years, I was born in 1962. I have had 6 strokes and 1 heart attack. The Rebif (beta-1a) did very little to help me. The medical team did even less. After roughly five unending years of trauma in the family my MS developed into progressive. There have been many changes in the last 3 to 4 years. Many falls, many fractured bones, and three moves all in five years. I have gone downhill. Considerably. I used different supplements that didn't work. I started on MS-4 Protocol from www. Limitlessnaturalwellness .com , the MS-4 Protocol immensely helped my Multiple Sclerosis condition, I'm able to walk and the constant fatigues are gone. My life is back. I Adhere anyone reading this to try natural approach.
Guidelines
Brazil's ANVISA updates guidance on pharmacokinetic studies for biosimilars
Canada eliminates phase III trial requirement for biosimilar approvals
Policies & Legislation
ANVISA updates understanding on biosimilar interchangeability
China's 12th VBP round accelerates shift to generics and biosimilars dual-track
Most viewed articles
The best selling biotechnology drugs of 2008: the next biosimilars targets
Global biosimilars guideline development – EGA’s perspective
Related content
Sun Pharma completes $11.75bn financing syndication for Organon acquisition
Sun Pharma's Organon deal set to reshape biosimilars competitive landscape
Amgen expansion, BioNTech retrenchment highlight diverging manufacturing strategies in biopharma
Brazil's EMS acquires Medley for R$3.6 billion, targets US market after 2030
Sun Pharma completes $11.75bn financing syndication for Organon acquisition
Home/Pharma News Posted 20/08/2026
Sun Pharma's Organon deal set to reshape biosimilars competitive landscape
Home/Pharma News Posted 12/06/2026
Amgen expansion, BioNTech retrenchment highlight diverging manufacturing strategies in biopharma
Home/Pharma News Posted 05/06/2026
Brazil's EMS acquires Medley for R$3.6 billion, targets US market after 2030
Home/Pharma News Posted 06/05/2026
The best selling biotechnology drugs of 2008: the next biosimilars targets
Post your comment